{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:41:51Z","timestamp":1774485711727,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.amjms.2016.06.013","type":"journal-article","created":{"date-parts":[[2016,7,2]],"date-time":"2016-07-02T23:57:53Z","timestamp":1467503873000},"page":"354-359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Assessment of Apelin Serum Levels in Persistent Atrial Fibrillation and Coronary Artery Disease"],"prefix":"10.1016","volume":"352","author":[{"given":"Mehrnaz","family":"Riazian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elnaz","family":"Khorrami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Alipoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sina","family":"Moradmand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Yaseri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Javad","family":"Hosseinzadeh-Attar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.amjms.2016.06.013_bib1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/bbrc.1998.9489","article-title":"Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor","volume":"251","author":"Tatemoto","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"issue":"2-3","key":"10.1016\/j.amjms.2016.06.013_bib2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0167-4889(00)00143-9","article-title":"Molecular properties of apelin: tissue distribution and receptor binding","volume":"1538","author":"Kawamata","year":"2001","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.1016\/j.amjms.2016.06.013_bib3","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1046\/j.1471-4159.2003.01587.x","article-title":"Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin","volume":"84","author":"Medhurst","year":"2003","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.amjms.2016.06.013_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12020-011-9507-9","article-title":"Apelin, diabetes, and obesity","volume":"40","author":"Castan-Laurell","year":"2011","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.amjms.2016.06.013_bib5","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1210\/en.2004-1427","article-title":"Apelin, a newly identified adipokine up-regulated by insulin and obesity","volume":"146","author":"Boucher","year":"2005","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.amjms.2016.06.013_bib6","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.RES.0000033522.37861.69","article-title":"Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility","volume":"91","author":"Szokodi","year":"2002","journal-title":"Circ Res"},{"issue":"11 suppl 1","key":"10.1016\/j.amjms.2016.06.013_bib7","first-page":"II187","article-title":"Apelin has in vivo inotropic effects on normal and failing hearts","volume":"110","author":"Berry","year":"2004","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.amjms.2016.06.013_bib8","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.bbrc.2007.04.017","article-title":"Direct effects of apelin on cardiomyocyte contractility and electrophysiology","volume":"357","author":"Farkasfalvi","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"issue":"2-3","key":"10.1016\/j.amjms.2016.06.013_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0167-0115(01)00236-1","article-title":"The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism","volume":"99","author":"Tatemoto","year":"2001","journal-title":"Regul Pept"},{"issue":"28","key":"10.1016\/j.amjms.2016.06.013_bib10","doi-asserted-by":"crossref","first-page":"10464","DOI":"10.1073\/pnas.0403518101","article-title":"Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release","volume":"101","author":"De Mota","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.amjms.2016.06.013_bib11","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ejheart.2008.06.002","article-title":"The role of apelin in cardiovascular function and heart failure","volume":"10","author":"Chandrasekaran","year":"2008","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.amjms.2016.06.013_bib12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cmet.2008.10.003","article-title":"Apelin stimulates glucose utilization in normal and obese insulin-resistant mice","volume":"8","author":"Dray","year":"2008","journal-title":"Cell Metab"},{"issue":"3","key":"10.1016\/j.amjms.2016.06.013_bib13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1753-0407.2011.00132.x","article-title":"Apelin and insulin resistance: another arrow for the quiver?","volume":"3","author":"Xu","year":"2011","journal-title":"J Diabetes"},{"issue":"3","key":"10.1016\/j.amjms.2016.06.013_bib14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/hrt.2003.014720","article-title":"Atrial fibrillation: an emerging epidemic?","volume":"90","author":"Steinberg","year":"2004","journal-title":"Heart"},{"issue":"8","key":"10.1016\/j.amjms.2016.06.013_bib15","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1253\/circj.CJ-13-0786","article-title":"Epidemiology of stroke and coronary artery disease in Asia","volume":"77","author":"Hata","year":"2013","journal-title":"Circ J"},{"issue":"2","key":"10.1016\/j.amjms.2016.06.013_bib16","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ahj.2007.10.004","article-title":"Atrial fibrillation and obesity\u2014results of a meta-analysis","volume":"155","author":"Wanahita","year":"2008","journal-title":"Am Heart J"},{"issue":"18","key":"10.1016\/j.amjms.2016.06.013_bib17","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1161\/01.CIR.0000145546.97738.1E","volume":"110","author":"Klein","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.amjms.2016.06.013_bib18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0735-1097(00)01107-4","article-title":"Epidemiology and natural history of atrial fibrillation: clinical implications","volume":"37","author":"Chugh","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"41","key":"10.1016\/j.amjms.2016.06.013_bib19","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1093\/eurheartj\/eht351","article-title":"Endothelial dysfunction over the course of coronary artery disease","volume":"34","author":"Gutierrez","year":"2013","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.amjms.2016.06.013_bib20","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.trsl.2010.01.004","article-title":"Serum levels of apelin and ghrelin in patients with acute coronary syndromes and established coronary artery disease\u2014KOZANI STUDY","volume":"155","author":"Kadoglou","year":"2010","journal-title":"Transl Res"},{"issue":"2","key":"10.1016\/j.amjms.2016.06.013_bib21","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/eurheartj\/ehi648","article-title":"Reduced apelin levels in lone atrial fibrillation","volume":"27","author":"Ellinor","year":"2006","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.amjms.2016.06.013_bib22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.amjcard.2009.08.656","article-title":"Effect of sinus rhythm restoration after electrical cardioversion on apelin and brain natriuretic Peptide prohormone levels in patients with persistent atrial fibrillation","volume":"105","author":"Kallergis","year":"2010","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.amjms.2016.06.013_bib23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/CRD.0b013e3181b3fe0d","article-title":"The emerging role of apelin in cardiovascular disease and health","volume":"17","author":"Quazi","year":"2009","journal-title":"Cardiol Rev"},{"issue":"3-4","key":"10.1016\/j.amjms.2016.06.013_bib24","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.cca.2011.11.021","article-title":"Apelin in acute myocardial infarction and heart failure induced by ischemia","volume":"413","author":"Tycinska","year":"2012","journal-title":"Clin Chim Acta"},{"issue":"8","key":"10.1016\/j.amjms.2016.06.013_bib25","doi-asserted-by":"crossref","first-page":"642","DOI":"10.2459\/JCM.0000000000000010","article-title":"The association between apelin-12 levels and paroxysmal supraventricular tachycardia","volume":"15","author":"Gurger","year":"2014","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"11","key":"10.1016\/j.amjms.2016.06.013_bib26","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1007\/s11695-009-9955-y","article-title":"Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus","volume":"19","author":"Soriguer","year":"2009","journal-title":"Obes Surg"},{"issue":"12","key":"10.1016\/j.amjms.2016.06.013_bib27","doi-asserted-by":"crossref","first-page":"e51236","DOI":"10.1371\/journal.pone.0051236","article-title":"Altered glucose homeostasis is associated with increased serum apelin levels in type 2 diabetes mellitus","volume":"7","author":"Cavallo","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.amjms.2016.06.013_bib28","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejogrb.2014.02.022","article-title":"Apelin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome","volume":"176","author":"Altinkaya","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"9","key":"10.1016\/j.amjms.2016.06.013_bib29","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.metabol.2011.02.005","article-title":"Lack of association between apelin, insulin resistance, cardiovascular risk factors, and obesity in children: a longitudinal analysis","volume":"60","author":"Reinehr","year":"2011","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.amjms.2016.06.013_bib30","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/cen.12404","article-title":"Circulating apelin is increased in patients with type 1 or type 2 diabetes and is associated with better glycaemic control","volume":"81","author":"Habchi","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.amjms.2016.06.013_bib31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3389\/fphys.2015.00115","article-title":"Apelin and energy metabolism","volume":"6","author":"Bertrand","year":"2015","journal-title":"Front Physiol"},{"issue":"2","key":"10.1016\/j.amjms.2016.06.013_bib32","first-page":"99","article-title":"Relationship of vaspin and apelin levels with insulin resistance and atherosclerosis in metabolic syndrome","volume":"39","author":"Karbek","year":"2014","journal-title":"Minerva Endocrinol"},{"issue":"4","key":"10.1016\/j.amjms.2016.06.013_bib33","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.metabol.2010.05.008","article-title":"Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease","volume":"60","author":"Aktas","year":"2011","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.amjms.2016.06.013_bib34","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1055\/s-2007-971067","article-title":"Plasma apelin is lower in patients with elevated LDL-cholesterol","volume":"115","author":"Tasci","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962916303706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962916303706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T15:50:50Z","timestamp":1536594650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962916303706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0002962916303706"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2016.06.013","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of Apelin Serum Levels in Persistent Atrial Fibrillation and Coronary Artery Disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2016.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Southern Society for Clinical Investigation. Published by All rights reserved.","name":"copyright","label":"Copyright"}]}}